Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 04, 2021

SELL
$36.62 - $51.69 $6.3 Million - $8.89 Million
-172,081 Closed
0 $0
Q1 2021

Apr 20, 2021

SELL
$41.56 - $59.88 $24,811 - $35,748
-597 Reduced 0.35%
172,081 $8.3 Million
Q4 2020

Jan 20, 2021

SELL
$36.08 - $56.47 $349,254 - $546,629
-9,680 Reduced 5.31%
172,678 $9.3 Million
Q3 2020

Oct 14, 2020

SELL
$33.26 - $40.48 $1.87 Million - $2.27 Million
-56,100 Reduced 23.53%
182,358 $6.73 Million
Q2 2020

Jul 15, 2020

SELL
$24.21 - $31.02 $13,799 - $17,681
-570 Reduced 0.24%
238,458 $7.39 Million
Q1 2020

Apr 27, 2020

SELL
$20.5 - $34.53 $2.52 Million - $4.24 Million
-122,830 Reduced 33.94%
239,028 $6.6 Million
Q4 2019

Jan 17, 2020

SELL
$18.96 - $29.84 $38,678 - $60,873
-2,040 Reduced 0.56%
361,858 $10.6 Million
Q3 2019

Oct 16, 2019

BUY
$19.12 - $26.24 $299,992 - $411,705
15,690 Added 4.51%
363,898 $6.96 Million
Q2 2019

Jul 19, 2019

BUY
$19.57 - $24.1 $18,787 - $23,136
960 Added 0.28%
348,208 $7.64 Million
Q1 2019

Apr 15, 2019

SELL
$12.14 - $20.46 $2.08 Million - $3.51 Million
-171,320 Reduced 33.04%
347,248 $7.11 Million
Q4 2018

Jan 15, 2019

SELL
$11.24 - $18.5 $5.67 Million - $9.33 Million
-504,132 Reduced 49.29%
518,568 $6.54 Million
Q3 2018

Oct 11, 2018

SELL
$12.5 - $15.38 $46,875 - $57,675
-3,750 Reduced 0.37%
1,022,700 $15.7 Million
Q2 2018

Jul 17, 2018

SELL
$7.99 - $14.05 $762,325 - $1.34 Million
-95,410 Reduced 8.5%
1,026,450 $13.5 Million
Q1 2018

Apr 16, 2018

BUY
$7.23 - $8.76 $650 - $788
90 Added 0.01%
1,121,860 $9.15 Million
Q4 2017

Jan 16, 2018

SELL
$8.02 - $11.18 $86,656 - $120,799
-10,805 Reduced 0.95%
1,121,770 $9.94 Million
Q3 2017

Oct 17, 2017

BUY
$9.11 - $11.26 $10.3 Million - $12.8 Million
1,132,575
1,132,575 $12.6 Million

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $1.75B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Summit Creek Advisors LLC Portfolio

Follow Summit Creek Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Creek Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit Creek Advisors LLC with notifications on news.